saxenda glp 1 agonist Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States Glucagon-like peptide-1 receptor agonists (GLP-1RAs)
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
![saxenda glp 1 agonist Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States Glucagon-like peptide-1 receptor agonists (GLP-1RAs)](https://images.everydayhealth.com/images/diet-nutrition/weight/prescription-weight-loss-medications-alt-1-1440x810.jpg?w=576)
![saxenda glp 1 agonist Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States Glucagon-like peptide-1 receptor agonists (GLP-1RAs)](https://www.svph.org.au/remote.axd/svhaprodaueprh0st.blob.core.windows.net/media/svph/media/svph/articles%20and%20news%20images/mhs/saxenda-2018-front-capped-pen-png.jpg?mode=crop&width=842&height=472&quality=80)
![saxenda glp 1 agonist Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States Glucagon-like peptide-1 receptor agonists (GLP-1RAs)](https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/927460ae5e7258b165e8e96356418d0499b1aba4-8192x5464.jpg)





















